Back to top
more

MACOM Technology Solutions (MTSI)

(Delayed Data from NSDQ)

$127.12 USD

127.12
5,914,965

-2.61 (-2.01%)

Updated Sep 19, 2025 04:00 PM ET

After-Market: $127.11 -0.01 (-0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.64%
2Buy17.83%
3Hold9.69%
4Sell5.29%
5Strong Sell2.54%
S&P50011.29%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value A Growth B Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 13% (31 out of 245)

Industry: Semiconductor - Analog and Mixed

Zacks News

Zacks Equity Research

Why Is Monolithic (MPWR) Down 3.5% Since Last Earnings Report?

Monolithic (MPWR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

MACOM (MTSI) Boosts Data Center Reach With New Product Family

MACOM (MTSI) unveils 226Gbps per lane technology product family, which comprises transimpedance amplifiers, externally modulated laser driver and photodiode.

Zacks Equity Research

MACOM (MTSI) Acquires Linearizer, Expands Product Portfolio

MACOM (MTSI) acquires Linearizer, which is known for correcting distortion in communications systems and linear optical links.

Zacks Equity Research

ADI vs. MTSI: Which Stock Is the Better Value Option?

ADI vs. MTSI: Which Stock Is the Better Value Option?

Zacks Equity Research

ADI or MTSI: Which Is the Better Value Stock Right Now?

ADI vs. MTSI: Which Stock Is the Better Value Option?

Zacks Equity Research

MACOM (MTSI) Q1 Earnings & Revenues Top Estimates, Rise Y/Y

MACOM's (MTSI) first-quarter fiscal 2023 results benefit from solid momentum across the Telecom market, Data center, and industrial and defense markets.

Zacks Equity Research

M/A-Com (MTSI) Surpasses Q1 Earnings and Revenue Estimates

M/A-Com (MTSI) delivered earnings and revenue surprises of 2.53% and 0.35%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

MACOM (MTSI) to Report Q1 Earnings: What's in the Offing?

MACOM's (MTSI) first-quarter fiscal 2023 results are likely to reflect strength in telecommunication, data center, industrial and defense markets amid supply chain disruptions.

Sejuti Banerjea headshot

3 Long-Term Picks from The Semiconductor Industry (Revised)

There are secular growth drivers of the Analog/Mixed Signal Semiconductor industry with near-term uncertainty leading to an attractive valuation. ADI, MTSI, and MCHP are worth exploring.

Zacks Equity Research

Zacks Industry Outlook Highlights Analog Devices, MACOM Technology and Microchip Technology

Analog Devices, MACOM Technology and Microchip Technology have been highlighted in this Industry Outlook article.

Sejuti Banerjea headshot

3 Long-Term Picks from the Semiconductor Industry

There are secular growth drivers of the Analog/Mixed Signal Semiconductor industry with near-term uncertainty leading to an attractive valuation. ADI, MTSI, and MCHP are worth exploring.

Zacks Equity Research

M/A-Com (MTSI) Surpasses Q4 Earnings and Revenue Estimates

M/A-Com (MTSI) delivered earnings and revenue surprises of 1.32% and 0.58%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Magnachip (MX) Q3 Earnings Top Estimates

Magnachip (MX) delivered earnings and revenue surprises of 150% and 1.46%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

NXP Semiconductors (NXPI) Q3 Earnings and Revenues Beat Estimates

NXP (NXPI) delivered earnings and revenue surprises of 36.07% and 0.55%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

M/A-Com (MTSI) Earnings Expected to Grow: Should You Buy?

M/A-Com (MTSI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

MaxLinear (MXL) Q3 Earnings and Revenues Top Estimates

MaxLinear (MXL) delivered earnings and revenue surprises of 0.96% and 0.25%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

M/A-Com (MTSI) Upgraded to Buy: Here's What You Should Know

M/A-Com (MTSI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Zacks Equity Research

ON vs. MTSI: Which Stock Is the Better Value Option?

ON vs. MTSI: Which Stock Is the Better Value Option?

Zacks Equity Research

The Zacks Analyst Blog Highlights Silicon Laboratories, MACOM Technology Solutions, Taiwan Semiconductor Manufacturing, STMicroelectronics N.V.

Silicon Laboratories, MACOM Technology Solutions, Taiwan Semiconductor Manufacturing, STMicroelectronics N.V. are part of the Zacks top Analyst Blog.

Zacks Equity Research

ON vs. MTSI: Which Stock Should Value Investors Buy Now?

ON vs. MTSI: Which Stock Is the Better Value Option?

Zacks Equity Research

Vishay (VSH) Q2 Earnings & Revenues Beat Estimates, Rise Y/Y

Vishay's (VSH) second-quarter results benefit from strong momentum across its resistor, inductor, diode, capacitor and opto product lines.

Zacks Equity Research

PayPal (PYPL) Q2 Earnings Beat Estimates, Revenues Rise Y/Y

PayPal's (PYPL) second-quarter results reflect the strong performance of Venmo and solid momentum in the United States.

Ritujay Ghosh headshot

4 Solid Stocks to Buy on Soaring Semiconductor Sales

Semiconductor shortage is crippling several industries but boosting microchip sales, helping Silicon Laboratories (SLAB), MACOM Technology Solutions (MTSI), Taiwan Semiconductor Manufacturing (TSM) and STMicroelectronics (STM).

Zacks Equity Research

AMETEK (AME) Q2 Earnings & Sales Beat Estimates, Rise Y/Y

AMETEK's (AME) second-quarter results reflect solid momentum in the EIG and EMG segments.

Zacks Equity Research

Waters (WAT) Q2 Earnings & Sales Surpass Estimates, Rise Y/Y

Waters' (WAT) second-quarter results reflect gains from a strong momentum across pharmaceutical and industrial end-markets, and geographical regions.